A detailed history of Atomi Financial Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 4,684 shares of MRNA stock, worth $319,823. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,684
Previous 2,111 121.89%
Holding current value
$319,823
Previous $225 Million 147.25%
% of portfolio
0.04%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$101.21 - $166.61 $260,413 - $428,687
2,573 Added 121.89%
4,684 $556 Million
Q1 2024

May 07, 2024

BUY
$85.37 - $115.44 $180,216 - $243,693
2,111 New
2,111 $225 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.